NCT03708822 2024-01-18
Study of Docetaxel and Cisplatin Combined With Nimotuzumab As First-Line Treatment in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 2 Unknown
Clinical Trials
6 trialsNCT03837808 2022-11-07
Radiotherapy Plus Concurrent Nimotuzumab or Cisplatin in Stage II-III Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 3 Unknown
NCT03915132 2021-01-29
Nimotuzumab Combined With VMAT in Elderly Patients With Nasopharyngeal Carcinoma
ChineseAMS
Phase 2 Unknown
NCT03557112 2018-11-02
By Comparing TPF Induction Chemotherapy Combined With Nimotuzumab Concurrent Radiotherapy and Cisplatin Concurrent Radio-chemotherapy for Locally Advanced NPC
Guiyang Medical University
Phase 2 Unknown
NCT03666221 2018-09-11
Nimotuzumab for Recurrent Nasopharyngeal Carcinoma
Fujian Cancer Hospital
Phase 2 Unknown
NCT02293356 2015-08-19
Phase IV Clinical Trial of Nimotuzumab in the Treatment of Nasopharyngeal Carcinoma
Biotech Pharmaceutical Co., Ltd.
Phase 4 Unknown